CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice

J Invest Dermatol. 2017 Apr;137(4):982-985. doi: 10.1016/j.jid.2016.10.048. Epub 2017 Jan 23.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / therapeutic use*
  • CD8-Positive T-Lymphocytes / immunology
  • Chemokine CXCL10 / physiology
  • Mice
  • Mice, Inbred C57BL
  • Receptors, CXCR3 / antagonists & inhibitors*
  • Receptors, CXCR3 / physiology
  • Vitiligo / drug therapy*

Substances

  • Antibodies
  • Chemokine CXCL10
  • Cxcl10 protein, mouse
  • Cxcr3 protein, mouse
  • Receptors, CXCR3